<?xml version="1.0" encoding="UTF-8"?>
<ref id="ajh25238-bib-0044">
 <label>44</label>
 <mixed-citation publication-type="journal" id="ajh25238-cit-0044">
  <string-name>
   <surname>Burnett</surname>
   <given-names>AK</given-names>
  </string-name>, 
  <string-name>
   <surname>Milligan</surname>
   <given-names>D</given-names>
  </string-name>, 
  <string-name>
   <surname>Goldstone</surname>
   <given-names>A</given-names>
  </string-name>, et al. 
  <article-title>The impact of dose escalation and resistance modulation in older patients with acute myeloid leukaemia and high risk myelodysplastic syndrome: the results of the LRF AML14 trial</article-title>. 
  <source xml:lang="en">Br J Haematol.</source>
  <year>2009</year>;
  <volume>145</volume>:
  <fpage>318</fpage>‚Äê
  <lpage>332</lpage>.
  <pub-id pub-id-type="pmid">19291085</pub-id>
 </mixed-citation>
</ref>
